Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Simari

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
American Journal of Physiology. Renal Physiology|February 1, 2013
Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis modelDiping Wang, Gina M Warner, Ping Yin, et al.
Physiological Genomics|February 12, 2004
Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networksJennifer L Hall, Suzanne Grindle, Xinqiang Han, et al.
Circulation Research|May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research networkRobert D Simari, Carl J Pepine, Jay H Traverse, et al.
Scientific Reports|September 19, 2018
Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidneyAmrutesh S Puranik, Irina A Leaf, Mark A Jensen, et al.
Contemporary Clinical Trials|July 20, 2011
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experienceLemuel A Moyé, Timothy D Henry, Kenneth W Baran, et al.
Scientific Reports|May 16, 2019
Vasculogenic properties of adventitial Sca-1<sup>+</sup>CD45<sup>+</sup> progenitor cells in mice: a potential source of vasa vasorum in atherosclerosisDeborah Toledo-Flores, Anna Williamson, Nisha Schwarz, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
European Heart Journal|September 13, 2013
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysisRonak Delewi, Alexander Hirsch, Jan G Tijssen, et al.
Circulation Research|December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year AnalysisJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
American Journal of Physiology. Renal Physiology|February 1, 2013
Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis modelDiping Wang, Gina M Warner, Ping Yin, et al.
Physiological Genomics|February 12, 2004
Genomic profiling of the human heart before and after mechanical support with a ventricular assist device reveals alterations in vascular signaling networksJennifer L Hall, Suzanne Grindle, Xinqiang Han, et al.
Circulation Research|May 10, 2014
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research networkRobert D Simari, Carl J Pepine, Jay H Traverse, et al.
Scientific Reports|September 19, 2018
Kidney-resident macrophages promote a proangiogenic environment in the normal and chronically ischemic mouse kidneyAmrutesh S Puranik, Irina A Leaf, Mark A Jensen, et al.
Contemporary Clinical Trials|July 20, 2011
Cell therapy and satellite centers: the Cardiovascular Cell Therapy Research Network experienceLemuel A Moyé, Timothy D Henry, Kenneth W Baran, et al.
Scientific Reports|May 16, 2019
Vasculogenic properties of adventitial Sca-1<sup>+</sup>CD45<sup>+</sup> progenitor cells in mice: a potential source of vasa vasorum in atherosclerosisDeborah Toledo-Flores, Anna Williamson, Nisha Schwarz, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
European Heart Journal|September 13, 2013
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysisRonak Delewi, Alexander Hirsch, Jan G Tijssen, et al.
Circulation Research|December 7, 2017
TIME Trial: Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year AnalysisJay H Traverse, Timothy D Henry, Carl J Pepine, et al.
Pageof 12